MPT vs VTR: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: MPT is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MPT and VTR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MPT and VTR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Medical Properties Trust, Inc. trades on the New York Stock Exchange under the ticker MPT and is one of the largest owners of hospital real estate in the world. Its model is sale-leaseback: it buys hospital buildings from operators, then leases the property back under long-term net leases where the tenant covers taxes, insurance, and maintenance. The portfolio spans general acute care hospitals, behavioral health facilities, and post-acute sites across the United States and Europe, and revenue comes almost entirely from contractual rent plus interest on loans MPT has made to some of its tenants.

Full MPT guide

Ventas, Inc. is an S&P 500 healthcare real estate investment trust that owns roughly 1,400 properties across North America and the United Kingdom, spanning senior housing communities, outpatient medical buildings, and research and lab (life science) assets. Its defining shift has been toward its senior housing operating portfolio (SHOP), which now accounts for more than half of net operating income and gives Ventas direct exposure to occupancy, rate, and margin trends rather than just fixed lease income. The company owns over 850 senior housing communities, and management has leaned hard into buying them, raising 2026 investment guidance to about $3 billion because acquiring communities has looked more attractive than building.

Full VTR guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• MPT drivers: Tenant re-tenanting and rent recovery; Deleveraging and refinancing runway.
• VTR drivers: Senior housing (SHOP) demographic tailwind; Capital deployment into acquisitions.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: MPT carries roughly $9.8 billion of debt against a market cap near $2.7 billion, so financial leverage magnifies both gains and losses and refinancing risk is real given maturities in 2026 and 2027. For VTR, as an operating (SHOP-heavy) REIT, Ventas carries more earnings variability than a pure net-lease landlord because occupancy, labor costs, and rate growth flow straight to NOI.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MPT if you believe its drivers more; VTR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MPT and VTR guides.

MPT. MPT trades at a mid-single-digit multiple of normalized funds from operations, a steep discount to larger healthcare REITs like Welltower and Ventas, which reflects its leverage and tenant risk rather than a bargain hiding in plain sight. Q1 2026 returned to net profit with about $252 million in quarterly revenue, but results were flattered by a one-time United Kingdom deferred tax benefit and cash-rent catch-ups. The valuation is a classic high-yield, high-risk setup where the discount and the danger are two sides of the same coin.

VTR. VTR trades around $96 with a market cap near $47 billion, making it the second-largest healthcare REIT behind Welltower. At roughly a mid-20s price-to-FFO multiple, the market is paying up for a fifth consecutive year of double-digit senior housing NOI growth. The dividend yield is modest for a REIT at about 2.1%, reflecting both the growth premium and a payout that management has been rebuilding since the pandemic.

Headline figures (approximate, JULY 2026): MPT shows revenue (ttm) ~$1.0 billion, market cap ~$2.7 billion, stock price ~$4.85, dividend yield ~7.5% (~$0.36/yr); VTR shows revenue (ttm) ~$5.7B, q1 2026 revenue ~$1.66B, normalized ffo/share (q1 2026) ~$0.94, 2026 ffo/share guidance ~$3.82-$3.89.

MPT and VTR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MPT and VTR exposure against your real portfolio. It is not an investment adviser.